Wu Xia, Wang Liting, Cong Meng, Shen Mi, He Qianru, Ding Fei, Shi Haiyan
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education and Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.
Department of Pathophysiology, School of Medicine, Nantong University, Nantong, China.
Ann Transl Med. 2020 Dec;8(24):1640. doi: 10.21037/atm-20-5965.
Skin precursor-derived Schwann cells (SKP-SCs) have been shown to benefit the recovery of spinal cord injury (SCI) and peripheral nerve injury (PNI) with motor dysfunction. However, the effect of extracellular vesicles (EVs) from SKP-SCs responsible for neuroregeneration remains unknown.
Based on the obtainment and identification of rat SKP-SCs and their derived EVs, the primary rat injury model of motoneurons resulting from axotomy or nerve crush , as well as the secondary rat ischemic hypoxic injury model of motoneuron exposure to oxygen-glucose-deprivation (OGD) , were treated with EVs from skin precursor-derived Schwann cells (SKP-SC-EVs), respectively. Then, the axonal outgrowth and regrowth was observed and compared, and cell viability as well as the protein kinase B/mammalian target of rapamycin/p70 S6 kinase (Akt/mTOR/p70S6K) signaling pathway was detected, moreover, rapamycin (an mTOR inhibitor) was used to further reveal the underlying molecular mechanism.
The internalization of SKP-SC-EVs by neuronal cells was identified and . Besides the pro-axonal outgrowth effect of SKP-SC-EVs, prospectively, the treatment of OGD-injured motoneurons with SKP-SC-EVs potentiated the restoration of neuronal viability and axonal regrowth. Furthermore, the axotomizing injury could be improved with SKP-SC-EVs treatment and . Finally, it was shown that the application of SKP-SC-EVs could activate the Akt/mTOR/p70S6K signaling pathway that can be abolished by rapamycin.
In summary, the addition of SKP-SC-EVs could regulate the cell growth and death signaling pathway mediated by Akt/mTOR/p70S6K, owing to the transmission of cargos in EVs to damaged motoneurons, which leads to axonal regrowth and neuronal resurrection. Thus, SKP-SC-EVs treatment could be a novel promising strategy for improving the axonal outgrowth and regeneration of motoneurons.
皮肤前体细胞衍生的雪旺细胞(SKP-SCs)已被证明有助于脊髓损伤(SCI)和伴有运动功能障碍的周围神经损伤(PNI)的恢复。然而,SKP-SCs来源的细胞外囊泡(EVs)在神经再生方面的作用尚不清楚。
在获得并鉴定大鼠SKP-SCs及其衍生的EVs后,分别用皮肤前体细胞衍生的雪旺细胞外囊泡(SKP-SC-EVs)处理因轴突切断或神经挤压导致的原代大鼠运动神经元损伤模型,以及运动神经元暴露于氧糖剥夺(OGD)的继发性大鼠缺血缺氧损伤模型。然后,观察并比较轴突的生长和再生情况,检测细胞活力以及蛋白激酶B/雷帕霉素哺乳动物靶点/p70核糖体蛋白S6激酶(Akt/mTOR/p70S6K)信号通路,此外,使用雷帕霉素(一种mTOR抑制剂)进一步揭示潜在的分子机制。
鉴定了神经元细胞对SKP-SC-EVs的内化。除了SKP-SC-EVs的促轴突生长作用外,前瞻性地,用SKP-SC-EVs处理OGD损伤的运动神经元可增强神经元活力的恢复和轴突再生。此外,SKP-SC-EVs治疗可改善轴突切断损伤。最后,结果表明,应用SKP-SC-EVs可激活Akt/mTOR/p70S6K信号通路,而雷帕霉素可消除该通路的激活。
总之,添加SKP-SC-EVs可调节由Akt/mTOR/p70S6K介导的细胞生长和死亡信号通路,这是由于EVs中的货物传递至受损的运动神经元,从而导致轴突再生和神经元复活。因此,SKP-SC-EVs治疗可能是一种改善运动神经元轴突生长和再生的新的有前景的策略。